TITLE

Amgen 1Q Profit Up 5%; Beats Wall Street Views

PUB. DATE
April 2012
SOURCE
MondayMorning;4/30/2012, Vol. 20 Issue 18, p1
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article informs that Amgen Inc. has released its financial report for the first-quarter of 2012. It states that the net income rose to 1.18 billion U.S. dollars from 1.13 billion U.S. dollars from selling of cancer treatment drugs and generated revenue of 9.2 percent to 4.05 billion U.S. dollars. It also informs that president Robert Bradway will be appointed as new chief executive officer (CEO) of Amgen Inc. after the retirement of current CEO Kevin Sharer.
ACCESSION #
74735000

 

Related Articles

  • Amgen resists pressure to split. Investor's Business Daily // Investors Business Daily;10/29/2014, pA02 

    The drug giant offered '15 revenue guidance of $20.8 bil-$21.3 bil, above consensus of $20.4 bil. And it guided EPS to $9.05-$9.40, topping views for $9. On Tue., Amgen announced an additional 5% head-count reduction that, with cuts announced last year, amounts to a 20% shrinkage in staff. CEO...

  • A Dose of Change. Fishman, Charles // Fast Company;Aug2001, Issue 49, p50 

    Interviews Kevin Sharer, CEO of biotechnology company Amgen Inc. in Thousand Oaks, California. Things he had to do to win credibility at the company; His experience working as a manager on a nuclear submarine; Description of his management style.

  • Making Big Drugs. Colvin, Geoff // Fortune International (Europe);7/20/2009, Vol. 160 Issue 2, p100 

    An interview with pharmaceutical company Amgen chief executive officer (CEO) Kevin Sharer is presented. Sharer comments on U.S. President Barack Obama's plans for health-care reform and cost reduction and whether that will be a problem for Amgen's expensive drugs. He comments on whether he...

  • Making Big Drugs. Colvin, Geoff // Fortune;7/20/2009, Vol. 160 Issue 2, p31 

    An interview with pharmaceutical company Amgen chief executive officer (CEO) Kevin Sharer is presented. Sharer comments on U.S. President Barack Obama's plans for health-care reform and cost reduction and whether that will be a problem for Amgen's expensive drugs. He comments on whether he...

  • Amgen Beats Q2 Estimates, Stays Quiet on M&A Front. Boggs, Jennifer // BioWorld Today;7/31/2013, Vol. 24 Issue 145, p1 

    The article reports on the issues discussed at the July 30, 2013 conference call of biotechnology firm Amgen Inc. The company reported that it has beat second quarter revenue and earnings estimates and has ended the quarter with about 22 billion U.S. dollars in cash. Chairman and chief executive...

  • Kevin Sharer. Boyle, Matthew // Fortune;12/12/2005, Vol. 152 Issue 12, p127 

    The article presents an interview with Kevin Sharer, the chief executive officer at Amgen. Sharer learned leadership qualities in the United States Navy as well as under Jack Welch of General Electric. Sharer states that all leaders have courage. He discusses the importance of constructive...

  • Amgen Names Chairman.  // Chemical Market Reporter;12/18/2000, Vol. 258 Issue 25, p12 

    Reports on the appointment of Kevin Sharer as chief executive officer and president of the company Amgen.

  • MEDICINE MAN. Vinas, Tonya // Industry Week/IW;Jan2005, Vol. 254 Issue 1, p28 

    Profiles Kevin Sharer, CEO of medical biotechnology Amgen Inc. in Thousand Oaks, California. Award received by Sharer; Importance of innovation; Overview of acquisitions made by Sharer; Views on managing innovation.

  • Kevin Sharer. M. B. // Fortune International (Europe);12/12/2005, Vol. 152 Issue 11, p45 

    The article presents an interview with Kevin Sharer, the chief executive officer at Amgen. Sharer learned leadership qualities in the United States Navy as well as under Jack Welch of General Electric. Sharer states that all leaders have courage. He discusses the importance of constructive...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics